BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure

By

BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure (press release)
BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCQB: BRTX), a life sciences company focused on cellular therapies for various personal medical applications, announced today it has closed on the previously announced license agreement with Regenerative Sciences, LLC for the licensing of a technique used for the treatment of bulging and herniated discs. This treatment encompasses a novel way of cell culturing and includes a medical device designed for the re-transpla...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.